Literature DB >> 11233671

[Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps].

H Hudecková1, S Straka, M Avdicová, S Rusnáková.   

Abstract

The epidemiological situation as regards measles, rubella and mumps in Slovakia before vaccination and after its introduction in 1996, is analysed. On the basis of model costs of treatment of these diseases before vaccination and costs of treatment in 1996 including costs of vaccination, the authors calculated the total saved costs (549.7 mil. Sk), cost-effectiveness (10,680 Sk), as well as the cost-benefit.

Entities:  

Mesh:

Year:  2001        PMID: 11233671

Source DB:  PubMed          Journal:  Epidemiol Mikrobiol Imunol        ISSN: 1210-7913            Impact factor:   0.444


  1 in total

Review 1.  Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Authors:  Joseph B Babigumira; Ian Morgan; Ann Levin
Journal:  BMC Public Health       Date:  2013-04-29       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.